北京生物医学工程

脐动脉在搏动流作用下脱细胞制备小口径组织工程血管支架的研究

Pulsatile Flow Used for Small Diameter Blood Vessel Scaffold Decellularized by Human Umbilical Artery

作者：陈圣杰刘硕李京倖赵莉敏汪川张帆董培青

单位：首都医科大学附属北京安贞医院（北京100029）

分类号：

出版年·卷·期（页码）：2010·29·5（511-516）

摘要：

探索利用搏动流对小口径血管进行脱细胞的方法。首先将脐动脉连接到搏动流管道中进行灌注，结合0.25％胰蛋白酶和0.01％乙二胺四乙酸混合溶液的共同作用，以1％十二烷基硫酸钠为脱细胞试剂对脐动脉洗脱3h。洗脱3h后的病理切片显示脐动脉细胞被全部脱去；拉伸实验测定脐动脉脱细胞前极限应力为（3.55±0.42）N，脱细胞后其极限应力为（3.50±0.43）N（P＞0.05）；在300mmHg压强作用下，脐动脉脱细胞前后两组（各30根血管）均有2根破裂，28根保持完好（P＞0.05）。此结果预示，脐动脉在脱细胞前后的力学特性无显著差异。成纤维细胞静态培养显示，成纤维细胞能在脱细胞脐动脉支架表面良好生长。研究结果表明利用搏动流将小口径血管脱细胞是一种简便、快速、有效的方法。

To explore the method of using pulsatile flow to decellularize small diameter blood vessels. First , the human umbilical arteries were poured with detergents and treated with 0.25% trypsin/0.01%EDTA 30 minutes. Then they were connected into a pulsatile flow circuit and decellularized by 1% sodium dodecyl sulfate (SDS) for 3 hours, when the arteries were completely acellularized and observed by pathologic examination. The tests on mechanics to the arteries indicated that the maximum tensile stress of the arteries was （3.55±0.42）N before decellularization and （3.50±0.43）N after decellularization(P＞0.05）. Two vessels ruptured and 28 vessels remained intact in the pressure range of 300 mmHg before and after decellularization. This test indicated that there was no significant difference in mechanical properties between treated arteries and untreated arteries. Additionally the static cultivation of fibroblasts displayed that the fibroblasts grew well on the umbilical artery scaffolds sheet. These results suggest that small diameter blood vessels can be decellularizied in pulsatile flow condition conveniently, rapidly and efficiently.

参考文献：

［1］Grigioni M, Daniele C, Avenio G, et al. Biomechanics and hemodynamics of grafting//Tura A, editor. Vascular grafts: experiment and modeling. Boston: WIT Press,2003: 41–82.
［2］Stegemann JP,Kaszuba SN,Rowe SL.Review: Advances in Vascular Tissue Engineering,Using Protein-Based Biomaterials. Tissue Engineering, 2007,11: 2601-2613.
［3］Hoerstrup SP,Zund G,Sodian R,et al.Tissue engineering of small caliber vascular grafts.Eur J Cardiothorac Surg,2001, 20:164-169.
［4］Sodian R,Hoerstrup SP,Sperling IS,et al.Evaluation of biodegr-adable, three-dimensional matrices for tissue engineering of heart valve.ASAIO J, 2000,46:107-110.
［5］Ye Q,Zund G,Benedikt P,et al.Fibrinsel as three dimensional matrix in cardiovas-cular tissue engineering. Eur J Cardiothorac Surg,2000,17:587-591.
［6］Scharn DM,Oyen WJG,Klemm PL,et al.Thrombogenicity and Related Biological Properties of Heparin Bonded Collagen Coated Polyester and Human Umbilical Vein Prosthetic Vascular Grafts. Journal of Surgical Research, 2006,134: 182-189.
［7］冯元桢.生物力学.北京：科学出版社，1983：155-184.
［8］Roh JD,Nelson GN,Brennan MP, et al.Small-diameter biodegradable scaffolds for functional vascular tissue engineering in the mouse model. Biomaterials,2008,29:1454-1463.
［9］Xu CY,Inai R,Kotaki M,et al.Aligned biodegradable nanofibrous structure: apotential scaffold for blood vessel engineering. Biomaterials, 2004, 25: 877-886.
［10］Divya Pankajakshan， Krishnan LK.Design of fibrin matrix composition to enhance endothelial cell growth and extracellular matrix deposition for in vitro tissue engineering.Artificial Organs,2009,33:16–25.
［11］L’Heureux N,Paquet S,Labbe R,et al. Acompletely biological tissue-engineered human blood vessel. J The Federation of American Societies for Experimental Biology,1998,12:47-56.
［12］Sunjay K, Gilad E, Kristine J, et al. Functional small-diameter neovessels created using endothelial progenitor cells expanded exvivo. Nature Medicine,2001,7: 1035-1040.
［13］Seung-Woo Cho, Kwon Kim, Sang Hyun Lim, et al. Smooth muscle-like tissue engineered with bone marrow stromal cells.Biomateriels,2004,25:2979-2986.

服务与反馈：

【文章下载】【加入收藏】

提示：您还未登录，请登录！点此登录